JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB19862

Anti-SCD1 antibody [CD.E10]

4

(8 Reviews)

|

(111 Publications)

Anti-SCD1 antibody [CD.E10] (ab19862) is a mouse monoclonal antibody detecting SCD1 in Western Blot, Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Over 80 publications
- Trusted since 2005

View Alternative Names

FADS5, SCD1, SCDOS, SCD, Stearoyl-CoA desaturase, hSCD1, Acyl-CoA desaturase, Delta(9)-desaturase, Fatty acid desaturase, Delta-9 desaturase

6 Images
Western blot - Anti-SCD1 antibody [CD.E10] (AB19862)
  • WB

Lab

Western blot - Anti-SCD1 antibody [CD.E10] (AB19862)

Lanes 1 - 4 : Merged signal (red and green). Green - ab19862 observed at 36 kDa. Red - loading control ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) observed at 55kDa.

ab19862 was shown to react with SCD1 in wild-type HeLa cells in western blot with loss of signal observed in SCD knockout cell line ab265220 (SCD knockout cell lysate ab257658). Wild-type and SCD knockout HeLa cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab19862 and ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-SCD1 antibody [CD.E10] (ab19862) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

SCD knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human SCD (SCD1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-scd-scd1-knockout-hela-cell-line-ab265220'>ab265220</a>)

Lane 3:

HepG2 cell lysate at 20 µg

Predicted band size: 42 kDa

Observed band size: 36 kDa

false

Flow Cytometry - Anti-SCD1 antibody [CD.E10] (AB19862)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-SCD1 antibody [CD.E10] (AB19862)

Overlay histogram showing HepG2 cells stained with ab19862 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab19862, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 80% methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SCD1 antibody [CD.E10] (AB19862)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SCD1 antibody [CD.E10] (AB19862)

ab19862 staining SCD in human skin.
Left panel : with primary antibody at 4 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers EDTA pH 9.0. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Immunocytochemistry - Anti-SCD1 antibody [CD.E10] (AB19862)
  • ICC

Lab

Immunocytochemistry - Anti-SCD1 antibody [CD.E10] (AB19862)

ICC/IF image of ab19862 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab19862, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Immunoprecipitation - Anti-SCD1 antibody [CD.E10] (AB19862)
  • IP

Unknown

Immunoprecipitation - Anti-SCD1 antibody [CD.E10] (AB19862)

SCD was immunoprecipitated using 0.5mg Hek293 whole cell extract, 10µg of Mouse monoclonal to SCD and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Hek293 whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab19862.
Secondary : Goat polyclonal to mouse IgG light chain specific (HRP) at 1/5000 dilution.
Band : 32kDa; SCD.

All lanes:

Immunoprecipitation - Anti-SCD1 antibody [CD.E10] (ab19862)

Predicted band size: 42 kDa

false

Western blot - Anti-SCD1 antibody [CD.E10] (AB19862)
  • WB

Lab

Western blot - Anti-SCD1 antibody [CD.E10] (AB19862)

ab19862 was shown to react with SCD1 in wild-type HeLa cells in Western blot with loss of signal observed in SCD1 knockout cell line ab265220. Wild-type HeLa and SCD1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab19862 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-SCD1 antibody [CD.E10] (ab19862) at 1/1000 dilution

Lane 1:

Wild-type HeLa lysate at 35 µg

Lane 2:

SCD1 knock-out HeLa lysate at 35 µg

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

CD.E10

Isotype

IgG2b

Carrier free

No

Reacts with

Human

Applications

IP, IHC-P, ICC/IF, Flow Cyt, WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human SCD.

O00767

Specificity

<p>This SCD1 antibody can bind to SCD5 very weakly in WB when SCD5 is overexpressed (&lt;10% cross-reactivity).</p>

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2b-kappa-monoclonal-7e10g10-isotype-control-ab170192'>ab170192</a> - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "4 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-SCD1 antibody [CD.E10] (ab19862) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of SCD1?
Anti-SCD1 [CD.E10] (ab19862) specifically detects a band for SCD1 (UniProt: O00767) at a molecular weight of 42kDa.

Trusted by the scientific community
Anti-SCD1 [CD.E10] (ab19862) was first used in a scientific publication in 2005 and has been cited over 80 times in peer-reviewed journals.

Reviewed by scientists
Anti-SCD1 [CD.E10] (ab19862) has over 5 independent reviews from customers.

Specificity confirmed
The specificity of Anti-SCD1 antibody [CD.E10] (ab19862) has been confirmed by Western blot testing in SCD Knockout HeLa cell line, ab265220.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Protein A affinity chromatography
Storage buffer
pH: 7.2 Preservative: 0.05% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Stearoyl-CoA desaturase-1 (SCD1) also known as delta-9-desaturase is an enzyme integral to the synthesis of monounsaturated fats. This enzyme converts saturated fatty acyl-CoAs to monounsaturated fatty acyl-CoAs by introducing a double bond between the ninth and tenth carbon atoms a process called desaturation. SCD1 has a molecular weight of approximately 45 kDa and expresses in a variety of tissues including the liver adipose tissue and heart.
Biological function summary

SCD1 plays a significant role in fatty acid metabolism by regulating the balance of saturated and unsaturated fatty acids which impacts membrane fluidity and cellular signaling. SCD1 does not function as part of a multi-protein complex acting independently in the endoplasmic reticulum. Its expression and activity influence lipid biosynthesis and storage affecting energy homeostasis and lipid composition in cells.

Pathways

Fatty acid synthesis and oxidation pathways extensively involve SCD1. It participates mainly in the lipogenesis pathway interacting with proteins like acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). SCD1 contributes to maintaining the ratio of oleate and palmitoleate key monounsaturated fatty acids important for cellular functions by integrating into the lipid metabolism network.

SCD1 is implicated in conditions like obesity and metabolic syndrome. Altered SCD1 activity links to insulin resistance as seen in obesity by modulating lipid profiles that influence insulin sensitivity. SCD1 associates with proteins like peroxisome proliferator-activated receptor gamma (PPARγ) which regulates adipogenesis emphasizing its role in metabolic disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Stearoyl-CoA desaturase that utilizes O(2) and electrons from reduced cytochrome b5 to introduce the first double bond into saturated fatty acyl-CoA substrates (PubMed : 15907797, PubMed : 18765284). Catalyzes the insertion of a cis double bond at the delta-9 position into fatty acyl-CoA substrates including palmitoyl-CoA and stearoyl-CoA (PubMed : 15907797, PubMed : 18765284). Gives rise to a mixture of 16 : 1 and 18 : 1 unsaturated fatty acids (PubMed : 15610069). Plays an important role in lipid biosynthesis. Plays an important role in regulating the expression of genes that are involved in lipogenesis and in regulating mitochondrial fatty acid oxidation (By similarity). Plays an important role in body energy homeostasis (By similarity). Contributes to the biosynthesis of membrane phospholipids, cholesterol esters and triglycerides (By similarity).
See full target information SCD

Publications (111)

Recent publications for all applications. Explore the full list and refine your search

Journal of Cancer 16:3960-3971 PubMed41049011

2025

SREBP1-SCD1 enhanced MUFAs Biosynthesis drives Nutrient Deprived Pancreatic cancer cell Ferroptosis Resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Zhengyang Zhang,Xiaojie Cai,Yi Gong,Aihua Gong,Xiang Liao,Jie Gao,Dongqing Wang

F1000Research 14:10 PubMed40657179

2025

A guide to selecting high-performing antibodies for Stearoyl-CoA desaturase (SCD1) (UniProt ID: O00767) for use in western blot, immunoprecipitation, and immunofluorescence.

Applications

Unspecified application

Species

Unspecified reactive species

Vera Ruíz Moleón,Charles Alende,Maryam Fotouhi,Sara González Bolívar,Riham Ayoubi,Carl Laflamme

iScience 28:112404 PubMed40469110

2025

Gallium disrupts endoplasmic reticulum iron metabolism to induce lipid metabolic reprogramming in glioblastoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Michael S Petronek,Jeffrey M Stolwijk,Amira Zaher,Stephenson B Owusu,John Cooke,Akalanka B Ekanayake,Alexei V Tivanski,Jingyun Lee,Cristina M Furdui

Nature communications 16:4889 PubMed40425563

2025

Depletion-dependent activity-based protein profiling using SWATH/DIA-MS detects serine hydrolase lipid remodeling in lung adenocarcinoma progression.

Applications

Unspecified application

Species

Unspecified reactive species

Tatjana Sajic,Matej Vizovišek,Stephan Arni,Rodolfo Ciuffa,Martin Mehnert,Sébastien Lenglet,Walter Weder,Hector Gallart-Ayala,Julijana Ivanisevic,Marija Buljan,Aurelien Thomas,Sven Hillinger,Ruedi Aebersold

Cell death & disease 16:308 PubMed40240362

2025

IGF2BP3/ESM1/KLF10/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming.

Applications

Unspecified application

Species

Unspecified reactive species

Anbo Gao,Juan Zou,Tian Zeng,Mei Qin,Xing Tang,Ting Yi,Guangming Song,Jie Zhong,Yuhuan Zeng,Wenchao Zhou,Qin Gao,Qunfeng Zhang,Juan Zhang,Yukun Li

International journal of biological sciences 21:1275-1293 PubMed39897035

2025

Exosomal mediated lipid metabolism, ferritinophagy and CoQ-dependent pathway contributes to the ferroptosis of keratinocyte in SJS/TEN.

Applications

Unspecified application

Species

Unspecified reactive species

Chen Zhang,Pei Qiao,ChunYing Xiao,ZiPeng Cao,JiaoLing Chen,Hui Fang,JianKang Yang,ZeHua Kang,ErLe Dang,Shuai Shao,BingYu Pang,QingYang Li,ZhenLai Zhu,ShengXian Shen,Akito Hasegawa,Riichiro Abe,HongJiang Qiao,Gang Wang,Meng Fu

Nature communications 16:1237 PubMed39890801

2025

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Valentin Van den Bossche,Julie Vignau,Engy Vigneron,Isabella Rizzi,Hannah Zaryouh,An Wouters,Jérôme Ambroise,Steven Van Laere,Simon Beyaert,Raphaël Helaers,Cédric van Marcke,Lionel Mignion,Elise Y Lepicard,Bénédicte F Jordan,Céline Guilbaud,Olivier Lowyck,Hajar Dahou,Antonella Mendola,Manon Desgres,Léo Aubert,Isabelle Gerin,Guido T Bommer,Romain Boidot,Perrine Vermonden,Aurélien Warnant,Yvan Larondelle,Jean-Pascal Machiels,Olivier Feron,Sandra Schmitz,Cyril Corbet

Cancer cell international 24:432 PubMed39726006

2024

Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Barbara Guerra,Kristina Jurcic,Rachelle van der Poel,Samantha Lynn Cousineau,Thomas K Doktor,Laura M Buchwald,Scott E Roffey,Caroline A Lindegaard,Anna Z Ferrer,Mohammad A Siddiqui,Laszlo Gyenis,Brage S Andresen,David W Litchfield

Acta biochimica et biophysica Sinica 57:770-781 PubMed39468929

2024

Anthocyanins and flavonoids derived from L. flower inhibit bladder cancer growth via suppressing fatty acid synthesis mediated by SREBP1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chenkai Liu,Jue Liu,Gao Liu,Yusong Song,Xiuyu Yang,Honglei Gao,Cheng Xiang,Jie Sang,Tianrui Xu,Jun Sang

EMBO molecular medicine 16:2749-2774 PubMed39433871

2024

Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Tobias Ackermann,Engy Shokry,Ruhi Deshmukh,Jayanthi Anand,Laura C A Galbraith,Louise Mitchell,Giovanny Rodriguez-Blanco,Victor H Villar,Britt Amber Sterken,Colin Nixon,Sara Zanivan,Karen Blyth,David Sumpton,Saverio Tardito
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com